Summary. The effects of a low dose of alloxan on the blood glucose, islet beta cell granulation, body weight, insulin resistance, glucose tolerance, and responses to fasting and growth hormone were studied in ob/ob mice, which respond to a single low dose of alloxan with a rapid (24 h) and long-term (108 day) significant decrease in blood glucose levels, and increase in islet beta cell granulation. Three weeks after alloxan administration, insulin resistance is ameliorated in alloxan-treated obese mice whose body weight is not significantly different from their obese controls. A low dose of alloxan has a therapeutic influence ou glucose management in ob/ob mice: reduced glycemia, improved glucose tolerance, and increased tolerance to fasting. Growth hormone induces a similar hyperglycemic response in alloxan-treated and control mice.
glucose management, insulin resistance and body weight, growth hormone.
In a preliminary report [24] it was shown that administration of a single low dose of alloxan to fivemonth old C56BL/6J ob/ob mice caused an immediate (20 h ) and long-lasting (56 day) increase in pancreatic beta cell granulation, which was accompanied by a concomitant decrease in glycemia and glycosuria.
The pancreatic islets of ob/ob mice are markedly vascular, and hypertrophied [8] ; the beta cells are generally degranulated, and the nucleii, nucleoli [10] and Golgi bodies [11] enlarged. The ob/ob mouse shows a number of metabolic abnormalities [1, 3, 4, 5, 14, 17, 25] , including insensitivity to high doses of insulin [2, 23] , and a rapid response to the hyperglycemic action of growth hormone [18, 22] .
In this study the long-term (176 day) effect of a single low dose of alloxan on the body weight, blood glucose levels, islet beta cell granulation, insulin resistance, glucose tolerance and response to growth hormone was examined in the obese hyperglycemic mouse. mice were treated with Mloxan. All animals were fasted for 48 h, after which the appropriate obese and lean mice were treated with a single intraperitoneal injection of Mloxan and immediately returned to ad lib.
Materials and Methods
feeding. Alloxan dosage was the same as that used in an earlier study [24] : lean mice received 170 mg/kg body weight; obese mice received 85 mg/kg. Body weights and blood sugar levels were measured at various intervals from the day of Mloxan administration to 176 days post-Mloxan. The Somogyi-Nelson [19] micromethod was used to determine blood glucose from duplicate samples. Some animals from each group were chosen at random and sacrificed at various times from day one to day 176 after alloxan and the pancreata were removed at necropsy for histological examination. Panereata were placed in Bouin's solution and stained with Gomori's aldehyde fuchsin [7] after oxidation with acidified permanganate, and counterstained with HMmi's [9] method.
Fasting and Insuli~
Fifteen days after the single dose of alloxan, the obese mice were fasted for 24 h (water was accessible), and fasting body weights and blood glucose levels were determined. Twenty-two days after Mloxan administration food was withdrawn from the obese mice two hours before they were injected subcutaneously with 20 units NPtI insulin per kilogram body weight ; blood samples were obtained two hours after insulin administration. The mice were then returned to feeding. Lean mice were fasted overnight on the eleventh postalloxan day to determine fasting blood glucose levels. On the fifteenth post-Mloxan day food was removed from lean mice for two hours before they were injected subcutaneously with 10 units NPH insulin per kilogram; blood samples were taken two hours later, and the mice re-fed,
Glucose Tolerance Tests
At fifty-seven days post-alloxan (for the obese), and 45 days (for the lean), the mice were fasted overnight. Blood samples were obtained from the fasting mice, and then one, two and four hours after intraperitoneal administration of glucose. The lean mice received 20 mg glucose; the obese received 50 mg glucose. Food was withheld during this period.
At 120 days post-alloxan, a second glucose tolerance test was run on the same obese mice; after an overnight fast, blood glucose samples were taken from fasting mice and then 15, 30 and 60 rain after intraperitoneal administration of 50 mg of glucose.
Growth Hormone
In an effort to determine the effect of growth hormone on the blood glucose of alloxanized obese mice, a new group of fourteen 4 month old female C57BL/6J oh~oh mice was obtained from Jackson Memorial Laboratories and maintained on Purina Laboratory Chow ad lib. Body weights and blood glucose levels were determined 13 and 3 days before ceived 2 mg beef growth hormone subcutaneously. Twelve hours later, blood glucose levels were determined and the animals were sacrificed. The four remaining mice from each group received 1 mg growth hormone per day for 3 days, from day 7 to day 9 postalloxan. On the tenth day, blood glucose levels were determined and the animals sacrificed.
Results

Body Weight and Blood Glucose Levels in Long-Term
Alloxanized Animals The blood sugar levels and body weights of alloxantreated obese mice and their controls are shown in Fig. 1 . Twenty four hours after alloxan, the blood glucose levels of obese mice were lower than those of the non-treated obese controls. Forty eight hours postalloxan, the blood sugar of the control (non-alloxanized) obese mice was back to its high level whereas that of the alloxanized obese mice was significantly (:D-----< 0.01) lower.
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BLOOD GLUCOSE (mg/lO0 ml) alloxan administration. With these base lines established, all mice were fasted for 48 h, and randomized into two groups: 7 obese mice were treated with a single intraperitoneal injection of alloxan (85 mg/kg body weight); the remaining 7 obese mice served as nonalloxanized controls. Both groups were immediately returned to ad lib. feeding. Blood glucose levels and body weights were determined for both groups on the second, fourth, and seventh post-alloxan day.
On the seventh day, 3 mice from each group re-
The blood glucose values of alloxan-treated obese mice remained significantly (p -----< 0.01, p= <0.05) lower than obese controls for a period of 108 days postalloxan. About 108 days after alloxan administration, the blood glucose levels of both the alloxan-treated and control mice began to decline (Fig. 1) . From 116 to 162 days after alloxan administration, the blood sugar values of alloxan-treated obese mice remained consistently, but not significantly, lower than control values, until the 176th day post-alloxan, when the blood glucose levels of alloxan-treated mice were higher than controls. Body weight of alloxan-treated obese mice was similar to control values throughout the experimental period.
Alloxan-treated lean mice (Fig. 2) showed the expected blood glucose response to alloxan administration. There was an initial hypoglycemia 20 h postalloxan; glueosuria and hyperglycemia occurred 48 h after alloxan, and persisted throughout the 176 day experimental period. Over this same period, the control lean mice showed normal blood sugar values and gained 4.3 g, while the alloxan-treated lean mice gained 0.6 g.
Insulin Administration and Fasting
In obese mice, the percentage decrease in blood glucose following a large dose (20 units/kg) of insulin was greater in alloxan-treated than in non-alloxanized obese mice (Fig. 1) ; the blood glucose values of alloxanized mice fell from a fasting level of 137 to 94 mg per 100 ml (a 31 percent decrease) ; that of non-alloxanized, obese females was depressed from a fasting level of 195 to 165 mg per 100 ml (a 15% decrease). After inmice showed a 60% decrease, lean controls a 37% decrease, after a nineteen hour fast (Fig. 2) .
Glucose Tolerance Tests
The responses of the same obese mice at 7 months of age (57 days post-alloxan) and 9 months of age (120 days post-alloxan) to glucose tolerance tests are shown in Fig. 3 . When blood samples were taken from fasting mice and then 1, 2 and 4 h after a glucose load (57 days post-alloxan), the blood sugar responses of both the alloxan-treated and control obese mice were obtunded. When blood samples of the same mice were taken from fasting animals and then 15, 30 and 60 rain after glucose infusion (120 days post-alloxan) there was a sharp rise at 15 min and a slight depression in blood sugar levels at 30 rain of both the alloxanized and control obese mice. However, by 60 min the blood glucose levels of alloxanized mice were sharply depressed, whereas the blood glucose levels of non-alloxanized obese mice remained high. The glucose tolerance curves obtained 45 days after alloxan administration from alloxan-treated and control lean mice, one, two and Each point represents a mean obtained from 6 to 10 alloxan-treated and 6 or 7 control mice, and the vertical bars show the standard error of the mean sulin administration (Fig. 2) , the blood glucose of alloxanized lean mice fell from a fasting level of 192 to 83 mg per 100 ml (a 57% decrease); lean controls showed an ll%decrease (from 73 to 65 mg per 100 ml). After a twenty-nine hour fast, there was a 37~o decrease (from a pre-fast value of 217 to 137 mg per 100 ml) in blood glucose values of alloxan-treated obese mice; non-alloxanized obese mice showed a greater (52%) fall in blood sugar levels, from a pre-fast level of 406 to 195 mg per 100 ml, (Fig. 1) . Alloxanized lean four hours after 20 mg glucose were typical of diabetic and normal responses.
Growth Hormone
Growth hormone elicits a similar hyperglycemic response in alloxan-treated as in non-alloxanized, contro] obese mice (Fig. 4) . Twelve hours after administration of 2 mg growth hormone, the blood glucose levels of alloxan-treated mice were increased 33%. Blood sugar values of control mice increased 29~o. After 3 days of growth hormone administration (t mg per day), blood glucose levels of alloxan-treated obese mice were increased 41%; blood sugar values of control obese mice increased 480/0 .
Alloxan and Islet Histology
The hypertrophied, relatively degranulated islet tissue of an untreated obese mouse is shown in Fig. 5 . Twelve days after alloxan, the beta cells of obese mice were well granulated (Fig. 6) and appeared healthy.
The beta cells of an obese mouse are seen to be relatively well granulated 60 days after treatment with alloxan (Fig. 7) . The beta cells of a lean mouse twenty four hours after alloxan are so heavily granulated that cellular outlines are difficult to define. Forty eight hours after alloxan in the lean mouse, evidence of beta cell destruction is clear, and by 72 h the beta cells were either degranulated or contained dense granules and pyknotie nuclei. 
Discussion
The concept that insulin sensitivity is related to body weight has recently gained attention [I] . IV[ahler and Szabo [16] found that several days after alloxan administration, insulin resistance was ameliorated in ob/ob mice without a decrease in body weight. We find that twenty-two days after alloxan administration, when sufficient time is allowed for physiological adjustment to experimental conditions, insulin resistance is ameliorated in alloxan-treated obese mice whose body weight (54.2 =L 1.6 g) is not significantly different from that of their obese controls (56.5 ~ 1.9 g).
l-lerberg etal. [12] reported that in non-fasting oh~oh mice the peak of blood glucose values during glucose tolerance tests a p p e a r e d t w e n t y minutes after glucose injection, and t h a t the subsequent slope was similar in most groups, b u t delayed in mice older t h a n 7 months.
I n the present experiment, when the blood sugar responses of fasting 7 m o n t h old alloxanized and cont r o l obese mice are e x a m i n e d 1, 2 and 4 h after a glucose load, b o t h the a l l o x a n -t r e a t e d and control mice a p p e a r to have an o b t u n d e d response. However, closer inspection, a t 15, 30 and 60 rain, of the glucose tolerance tests of fasting, 9 m o n t h old, alloxanized and control obese mice shows t h a t b y 60 rain the blood glucose levels of alloxanized mice is s h a r p l y depressed, whereas control levels r e m a i n high. This suggests t h a t Mloxanized mice have a more a p p r o p r i a t e response to a glucose challenge than do their obese controls. In addition, the increased ability of alloxan-treated obese mice to tolerate a fast indicates that a low dose of alloxan may have a therapeutic effect on glucose management in the obese mouse.
The hyperglycemic response of ob/ob mice to growth hormone is well documented [18, 22] . Our results on the effect of growth hormone in alloxanized obese mice indicate that growth hormone elicits a similar hyperglycemic response in alloxan-treated and control ob/ob mice.
The effect of alloxan on islet cell granulation in ob/ ob mice should be considered from the point of view of age, body weight, glucose tolerance, serum insulin and blood glucose levels, since Herberg et al. have shown [12] that in the ob/ob mouse beta eel] granulation and glucose management vary with age. Our data indicate that a low dose of alloxan (85 mg/kg), when injected during the transitional phase, tends to permit the beta cells of the female ob/ob mouse to become, and remain, relatively well granulated. In this study, increased granulation of the islet beta cell is accompanied by a decrease in glyeemia. Association of increased beta cell granulation with reduction in blood glucose levels is not unique to the ob/ob mouse. Coleman et al. [6] report that regrannlation of the islet beta cells is associated with the maintenance of lower blood glucose levels in db/db mice.
The effect of alloxan appears to be dose related in ob/ob mice. The response to low doses of alloxan (85 mg/kg) may be similar to the initial, transient (and perhaps stimulatory) phase of alloxan action [13, 15, 21, 26] ; in the obese mouse a low dose of alloxan appears to elicit an arrest at the hypergranulation phase, with its accompanied decrease in glycemia and glucosuria. At this dose insulin resistance is ameliorated. When alloxan is given at 100 mg/kg [16] , the beta cells are reduced in size and contain fewer granules, but blood glucose is not increased and insulin resistance continues to be ameliorated. At 150 mg/kg [20] the beta cells are largely destroyed and blood sugar levels are strongly elevated.
A low dose of alloxan appears to have a long term therapeutic effect on glucose management in 5 month old of female C57BL/6J ob/ob mice. After alloxan, the pancreatic beta cells are relatively more. granular and glyeemia remains reduced for over 3 months. The responses to fasting and glucose tolerance tests are more appropriate in alloxan-treated mice than in their obese controls. While alloxanized mice continue to gain weight at the same rate as controls, insulin resistance is ameliorated, and the hyperglycemic response to growth hormone is unchanged.
